Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
HCAT

HCAT - Health Catalyst Inc Stock Price, Fair Value and News

$2.17-0.05 (-2.25%)
Market Closed

56/100

HCAT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

56/100

HCAT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.48

Target 3M

$2.31

Target 6M

$2.36

HCAT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HCAT Price Action

Last 7 days

-5.6%

Last 30 days

-13.9%

Last 90 days

-33.8%

Trailing 12 Months

-62.6%

HCAT RSI Chart

HCAT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HCAT Valuation

Market Cap

153.5M

Price/Earnings (Trailing)

-1.43

Price/Sales (Trailing)

0.49

Price/Free Cashflow

-11.11

HCAT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.48

Target 3M

$2.31

Target 6M

$2.36

HCAT Fundamentals

HCAT Revenue

Revenue (TTM)

316.1M

Rev. Growth (Yr)

-0.04%

Rev. Growth (Qtr)

-5.45%

HCAT Earnings

Earnings (TTM)

-107.6M

Earnings Growth (Yr)

-50.95%

Earnings Growth (Qtr)

45.75%

HCAT Profitability

Return on Equity

-32.42%

Return on Assets

-18.33%

Free Cashflow Yield

-9%

HCAT Investor Care

Shares Dilution (1Y)

16.24%

Diluted EPS (TTM)

-1.59

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025311.3M316.1M316.1M0
2024296.8M299.5M302.1M306.6M
2023282.0M284.6M290.0M295.9M
2022254.2M265.2M271.8M276.2M
2021199.6M215.9M230.5M241.9M
2020164.8M171.3M179.1M188.8M
2019127.2M141.0M147.5M154.9M
2018086.2M99.4M112.6M
201700073.1M
Get all data in R, Python etc through our Historical Stock Data APIs

About Health Catalyst Inc

HCAT
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
 CEO
 WEBSITEhealthcatalyst.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES1200

Health Catalyst Inc Frequently Asked Questions

HCAT is the stock ticker symbol of Health Catalyst Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Health Catalyst Inc is 153.49 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check HCAT's fair value in chart for subscribers.

The fair value guage provides a quick view whether HCAT is over valued or under valued. Whether Health Catalyst Inc is cheap or expensive depends on the assumptions which impact Health Catalyst Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HCAT.

As of Wed Jan 28 2026, HCAT's PE ratio (Price to Earnings) is -1.43 and Price to Sales (PS) ratio is 0.49. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HCAT PE ratio will change depending on the future growth rate expectations of investors.